Approval · Notice of Compliance 32662 · 2024
LEFLUNOMIDE: Notice of Compliance 32662
Issued February 7, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32662
- Date
- February 7, 2024
- Company
- Pro Doc LimiteeLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Admin
- Reason
- Administrative: Labelling Update (to match Licensor)
- Canadian reference product
- ARAVA (Aventis Pharma Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LEFLUNOMIDE | Not yet assigned | — |
Medicinal ingredients
- LEFLUNOMIDE 10 MG per TAB
- LEFLUNOMIDE 20 MG per TAB